BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16697650)

  • 1. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl.
    Turchan-Cholewo J; Liu Y; Gartner S; Reid R; Jie C; Peng X; Chen KC; Chauhan A; Haughey N; Cutler R; Mattson MP; Pardo C; Conant K; Sacktor N; McArthur JC; Hauser KF; Gairola C; Nath A
    Neurobiol Dis; 2006 Jul; 23(1):109-19. PubMed ID: 16697650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system].
    Merino JJ; Montes ML; Blanco A; Bustos MJ; Oreja-Guevara C; Bayon C; Cuadrado A; Lubrini G; Cambron I; Munoz A; Cebolla S; Gutierrez-Fernandez M; Bernardino JI; Arribas JR; Fiala M
    Rev Neurol; 2011 Jan; 52(2):101-11. PubMed ID: 21271550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif.
    Mishra M; Vetrivel S; Siddappa NB; Ranga U; Seth P
    Ann Neurol; 2008 Mar; 63(3):366-76. PubMed ID: 18074388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes.
    Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
    Neurobiol Dis; 2012 Feb; 45(2):657-70. PubMed ID: 22036626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, decreased vulnerability of PC12 cells to human immunodeficiency virus tat protein through attenuating calcium overload.
    Hui B; Li J; Geng MY
    J Neurosci Res; 2008 Apr; 86(5):1169-77. PubMed ID: 18092356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of apoE genotype and vitamin E on biomarkers of oxidative stress in cultured neuronal cells and the brain of targeted replacement mice.
    Huebbe P; Jofre-Monseny L; Boesch-Saadatmandi Ch; Minihane AM; Rimbach G
    J Physiol Pharmacol; 2007 Dec; 58(4):683-98. PubMed ID: 18195481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
    Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain.
    Podhaizer EM; Zou S; Fitting S; Samano KL; El-Hage N; Knapp PE; Hauser KF
    J Neuroimmune Pharmacol; 2012 Dec; 7(4):877-91. PubMed ID: 22101471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for spermine oxidase as a mediator of reactive oxygen species production in HIV-Tat-induced neuronal toxicity.
    Capone C; Cervelli M; Angelucci E; Colasanti M; Macone A; Mariottini P; Persichini T
    Free Radic Biol Med; 2013 Oct; 63():99-107. PubMed ID: 23665428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells.
    Ronaldson PT; Bendayan R
    J Neurochem; 2008 Aug; 106(3):1298-313. PubMed ID: 18485102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death.
    Suzuki M; El-Hage N; Zou S; Hahn YK; Sorrell ME; Sturgill JL; Conrad DH; Knapp PE; Hauser KF
    Mol Neurodegener; 2011 Nov; 6():78. PubMed ID: 22093090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system.
    Mocchetti I; Nosheny RL; Tanda G; Ren K; Meyer EM
    Ann N Y Acad Sci; 2007 Dec; 1122():144-54. PubMed ID: 18077570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse cases.
    Malik S; Khalique H; Buch S; Seth P
    PLoS One; 2011 Mar; 6(3):e18116. PubMed ID: 21483469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons.
    Teodorof-Diedrich C; Spector SA
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30158296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the HIV-1 viral protein TAT on central neurotransmission: role of group I metabotropic glutamate receptors.
    Neri E; Musante V; Pittaluga A
    Int Rev Neurobiol; 2007; 82():339-56. PubMed ID: 17678970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.
    Fitting S; Zou S; El-Hage N; Suzuki M; Paris JJ; Schier CJ; Rodríguez JW; Rodriguez M; Knapp PE; Hauser KF
    Curr HIV Res; 2014; 12(6):424-34. PubMed ID: 25760046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats.
    Tang H; Lu D; Pan R; Qin X; Xiong H; Dong J
    Life Sci; 2009 Jul; 85(1-2):1-10. PubMed ID: 19345695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins.
    Rumbaugh JA; Li G; Rothstein J; Nath A
    J Neurovirol; 2007 Apr; 13(2):168-72. PubMed ID: 17505985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of apolipoprotein E genotype and dietary alpha-tocopherol on redox status and C-reactive protein levels in apolipoprotein E3 and E4 targeted replacement mice.
    Jofre-Monseny L; Huebbe P; Stange I; Boesch-Saadatmandi C; Frank J; Jackson K; Minihane AM; Rimbach G
    Br J Nutr; 2008 Jul; 100(1):44-53. PubMed ID: 18179727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.
    Hajieva P; Mocko JB; Moosmann B; Behl C
    J Neurochem; 2009 Jul; 110(1):118-32. PubMed ID: 19486265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.